<--- Back to Details
First PageDocument Content
Risk management / Safety engineering / National Industrial Chemicals Notification and Assessment Scheme / Occupational safety and health / Therapeutic Goods Administration / Good laboratory practice / Food and Drug Administration / Patient safety / Regulatory risk differentiation / Good manufacturing practice / Risk assessment / Health insurance
Date: 2016-03-10 18:29:52
Risk management
Safety engineering
National Industrial Chemicals Notification and Assessment Scheme
Occupational safety and health
Therapeutic Goods Administration
Good laboratory practice
Food and Drug Administration
Patient safety
Regulatory risk differentiation
Good manufacturing practice
Risk assessment
Health insurance

Appendix B.10 Department of Health Summary Health reported 59 measures during the year, with a total net regulatory saving of $96.8 million per year. In 2015, the Health Portfolio continued to contribute strongly to th

Add to Reading List

Source URL: www.cuttingredtape.gov.au

Download Document from Source Website

File Size: 41,57 KB

Share Document on Facebook

Similar Documents

IMDRF Presentation: Jurisdictional update - Australia

IMDRF Presentation: Jurisdictional update - Australia

DocID: 1paZs - View Document

Risk management / Safety engineering / National Industrial Chemicals Notification and Assessment Scheme / Occupational safety and health / Therapeutic Goods Administration / Good laboratory practice / Food and Drug Administration / Patient safety / Regulatory risk differentiation / Good manufacturing practice / Risk assessment / Health insurance

Appendix B.10 Department of Health Summary Health reported 59 measures during the year, with a total net regulatory saving of $96.8 million per year. In 2015, the Health Portfolio continued to contribute strongly to th

DocID: 1oUqD - View Document

2015 Annual Red Tape Reduction Report Appendix B.10 - Department of Health

2015 Annual Red Tape Reduction Report Appendix B.10 - Department of Health

DocID: 1oH8C - View Document

The Australian and New Zealand Medical Device Incident Report Investigation Scheme What is it? The Scheme is a joint venture between the Australian Therapeutic Goods Administration and Medsafe, the New Zealand Medicines

The Australian and New Zealand Medical Device Incident Report Investigation Scheme What is it? The Scheme is a joint venture between the Australian Therapeutic Goods Administration and Medsafe, the New Zealand Medicines

DocID: 1lTjb - View Document

AUSTRALIAN GOVERNMENT WARNINGS & OTHER ACTIONS ON PSYCHOTROPIC DRUGS The Therapeutic Goods Administration (TGA) is Australia’s drug regulatory agency. They are responsible for authorising the sale of drugs and medical

AUSTRALIAN GOVERNMENT WARNINGS & OTHER ACTIONS ON PSYCHOTROPIC DRUGS The Therapeutic Goods Administration (TGA) is Australia’s drug regulatory agency. They are responsible for authorising the sale of drugs and medical

DocID: 1jYXQ - View Document